Literature DB >> 8012698

Bradykinin-stimulated phosphoinositide metabolism in cultured canine tracheal smooth muscle cells.

C M Yang1, H C Hsia, S P Chou, R Ong, J T Hsieh, S F Luo.   

Abstract

1. Stimulation of bradykinin (BK) receptors coupled to phosphoinositide (PI) hydrolysis was investigated in canine cultured tracheal smooth muscle cells (TSMCs). BK, kallidin, and des-Arg9-BK, stimulated [3H]-inositol phosphates (IPs) accumulation in a dose-dependent manner with half-maximal responses (EC50) at 20 +/- 5, 13 +/- 4, and 2.3 +/- 0.7 nM, (n = 5), respectively. 2. D-Arg[Hyp3, D-Phe7]-BK and D-Arg[Hyp3, Thi5,8, D-Phe7]-BK, B2 receptor antagonists, were equipotent in blocking the BK-induced IPs accumulation with pKB = 7.1 and 7.3, respectively. 3. Short-term exposure of TSMCs to phorbol 12-myristate 13-acetate (PMA, 1 microM) attenuated BK-stimulated IPs accumulation. The concentrations of PMA that gave half-maximal and maximal inhibition of BK-induced IPs accumulation were 15 +/- 4 nM and 1 microM, n = 3, respectively. The inhibitory effect of PMA on BK-induced response was reversed by staurosporine, a protein kinase C (PKC) inhibitor, suggesting that the inhibitory effect of PMA was mediated through the activation of PKC. 4. Prolonged incubation of TSMCs with PMA for 24 h, resulted in a recovery of receptor responsiveness which may be due to down-regulation of PKC. The inactive phorbol ester, 4 alpha-phorbol 12, 13-didecanoate at 1 microM, did not inhibit this response. 5. The site of this inhibition was further investigated by examining the effect of PMA on AlF(4-)-induced IPs accumulation in canine TSMCs. AlF(4-)-stimulated IPs accumulation was inhibited by PMA treatment, suggesting that the G protein(s) can be directly activated by AlF4-, which is uncoupled from phospholipase C by PMA treatment. 6. Incubation of TSMCs in the absence of external Ca2+ or upon removal of Ca2+ by addition of EGTA, caused a decrease in IPs accumulation without changing the basal levels. Addition of Ca2+ (3-620 nM) to digitonin-permeabilized TSMCs stimulated IPs accumulation was obtained by inclusion of either guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) or BK. The combination of GTP gamma S and BK caused an additive effect on IPs accumulation.7. Pretreatment of TSMCs with cholera toxin enhanced BK-stimulated IPs accumulation, whereas there was no effect with pertussis toxin.8. These data suggest that BK-stimulated PI metabolism is mediated by the activation of BK B2 receptors coupling to a G protein which is not blocked by cholera toxin or pertussis toxin treatment and dependent on external Ca2+. The transduction mechanism of BK coupled to PI hydrolysis is sensitive to feedback regulation by PKC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012698      PMCID: PMC1910033          DOI: 10.1111/j.1476-5381.1994.tb14018.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

Review 1.  Modulation of neurotransmission in airways.

Authors:  P J Barnes
Journal:  Physiol Rev       Date:  1992-07       Impact factor: 37.312

2.  Maturational regulation of inositol 1,4,5-trisphosphate metabolism in rabbit airway smooth muscle.

Authors:  S M Rosenberg; G T Berry; J R Yandrasitz; M M Grunstein
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 3.  Multiple B2 kinin receptors in mammalian tissues.

Authors:  R Plevin; P J Owen
Journal:  Trends Pharmacol Sci       Date:  1988-11       Impact factor: 14.819

4.  Endothelin/sarafotoxin receptor induced phosphoinositide turnover: effects of pertussis and cholera toxins and of phorbol ester.

Authors:  R Galron; A Bdolah; Y Kloog; M Sokolovsky
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

5.  Mechanisms for activation and subsequent removal of cytosolic Ca2+ in bradykinin-stimulated neuronal and glial cell lines.

Authors:  G Reiser; F J Binmöller; F Donié
Journal:  Exp Cell Res       Date:  1990-01       Impact factor: 3.905

6.  Regulation of the formation of inositol phosphates by calcium, guanine nucleotides and ATP in digitonin-permeabilized bovine adrenal chromaffin cells.

Authors:  D A Eberhard; R W Holz
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

7.  Regulation of functional muscarinic receptor expression in tracheal smooth muscle cells.

Authors:  C M Yang; S P Chou; T C Sung; H J Chien
Journal:  Am J Physiol       Date:  1991-12

8.  Evidence for two high-affinity bradykinin binding sites in the guinea-pig lung.

Authors:  A Trifilieff; E B Haddad; Y Landry; J P Gies
Journal:  Eur J Pharmacol       Date:  1991-06-19       Impact factor: 4.432

9.  Antagonist binding reveals two heterogenous B2 bradykinin receptors in rat myometrial membranes.

Authors:  C Liebmann; M Schnittler; J M Stewart; S Reissmann
Journal:  Eur J Pharmacol       Date:  1991-07-09       Impact factor: 4.432

10.  Antibodies to the alpha q subfamily of guanine nucleotide-binding regulatory protein alpha subunits attenuate activation of phosphatidylinositol 4,5-bisphosphate hydrolysis by hormones.

Authors:  S Gutowski; A Smrcka; L Nowak; D G Wu; M Simon; P C Sternweis
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

View more
  11 in total

1.  Bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine cultured tracheal epithelial cells.

Authors:  S F Luo; S L Pan; W B Wu; C C Wang; C T Chiu; Y J Tsai; C M Yang
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Pharmacological and functional characterization of bradykinin receptors in canine cultured tracheal epithelial cells.

Authors:  S F Luo; C T Tsai; W B Wu; S L Pan; Y J Tsai; C M Yang
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Lipopolysaccharide enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells.

Authors:  S F Luo; C C Wang; C T Chiu; C S Chien; L D Hsiao; C H Lin; C M Yang
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Tumour necrosis factor-alpha- and interleukin-1beta-stimulated cell proliferation through activation of mitogen-activated protein kinase in canine tracheal smooth muscle cells.

Authors:  C M Yang; S F Luo; C C Wang; C T Chiu; C S Chien; C C Lin; L D Hsiao
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

5.  Interleukin-1beta enhances bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine tracheal smooth-muscle cells: involvement of the Ras/Raf/mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK pathway.

Authors:  C M Yang; C S Chien; C C Wang; Y M Hsu; C T Chiu; C C Lin; S F Luo; L D Hsiao
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

6.  Biphasic increase in cytosolic free calcium induced by bradykinin and histamine in cultured tracheal smooth muscle cells: is the sustained phase artifactual?

Authors:  Y Amrani; A Da Silva; O Kassel; C Bronner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

7.  Pharmacological characterization of bradykinin receptors in canine cultured tracheal smooth muscle cells.

Authors:  C M Yang; S F Luo; H C Hsia
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  The effect of cyclic AMP elevating agents on bradykinin- and carbachol-induced signal transduction in canine cultured tracheal smooth muscle cells.

Authors:  C M Yang; H C Hsia; S F Luo; J T Hsieh; R Ong
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

9.  Ca(2+)-dependent and -independent mechanism of cyclic-AMP reduction: mediation by bradykinin B2 receptors.

Authors:  H Sipma; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

10.  Ca2+ increase and Ca(2+)-influx in human tracheal smooth muscle cells: role of Ca2+ pools controlled by sarco-endoplasmic reticulum Ca(2+)-ATPase 2 isoform.

Authors:  Y Amrani; C Magnier; J Enouf; F Wuytack; C Bronner
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.